TRANEXAMIC ACID
TRANEXAMIC ACID is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: TRANEXAMIC ACID; Generic name: TRANEXAMIC ACID; Drug class: Antifibrinolytic Agent [EPC].
| Brand name | TRANEXAMIC ACID |
|---|---|
| Generic name | TRANEXAMIC ACID |
| Drug class | Antifibrinolytic Agent [EPC] |
| Manufacturer | ADVAGEN PHARMA LIMITED |
| Used for | 1 INDICATIONS AND USAGE Tranexamic acid tablets are indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential [see Clinical Studies ( 14 )]. Tranexamic acid tablets are an antifibrinolytic indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential. (1) |
| Dosage | 2 DOSAGE AND ADMINISTRATION 1,300 mg three times a day (3,900 mg/day) for a maximum of 5 days during monthly menstruation ( 2.1 ) Renal impairment : Lower dosage is needed (for a maximum of 5 days during menstruation) if serum creatinine concentration (Cr) is higher than 1.4 mg/dL ( 2.2 ) Cr above 1.4 mg/dL and ≤ 2.8 mg/dL: 1,300 mg two times a day (2,600 mg/day) Cr above 2.8 mg/dL and ≤ 5.7 mg/dL: 1,300 mg once a day (1,300 mg/day) Cr above 5.7 mg/dL: 650 mg once a day (650 mg/day) 2.1 Recommen |
| Active ingredient(s) | TRANEXAMIC ACID |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a843fa7-1266-4666-b23f-22fd313d24a1 |